ProShare Advisors’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-16,916
| Closed | -$103K | – | 2371 |
|
|
2021
Q3 | $103K | Sell |
16,916
-4,549
| -21% | -$27.7K | ﹤0.01% | 1914 |
|
|
2021
Q2 | $177K | Buy |
21,465
+2,961
| +16% | +$24.4K | ﹤0.01% | 2178 |
|
|
2021
Q1 | $166K | Buy |
18,504
+1,193
| +7% | +$10.7K | ﹤0.01% | 2084 |
|
|
2020
Q4 | $200K | Buy |
17,311
+4,003
| +30% | +$46.2K | ﹤0.01% | 1849 |
|
|
2020
Q3 | $139K | Buy |
13,308
+1,017
| +8% | +$10.6K | ﹤0.01% | 1484 |
|
|
2020
Q2 | $162K | Buy |
+12,291
| New | +$162K | ﹤0.01% | 1510 |
|
|
2020
Q1 | – | Sell |
-12,833
| Closed | -$266K | – | 1711 |
|
|
2019
Q4 | $266K | Sell |
12,833
-1,330
| -9% | -$27.6K | ﹤0.01% | 1419 |
|
|
2019
Q3 | $194K | Sell |
14,163
-474
| -3% | -$6.49K | ﹤0.01% | 1450 |
|
|
2019
Q2 | $180K | Sell |
14,637
-1,920
| -12% | -$23.6K | ﹤0.01% | 1460 |
|
|
2019
Q1 | $207K | Buy |
16,557
+187
| +1% | +$2.34K | ﹤0.01% | 1458 |
|
|
2018
Q4 | $185K | Sell |
16,370
-3,160
| -16% | -$35.7K | ﹤0.01% | 1389 |
|
|
2018
Q3 | $365K | Sell |
19,530
-711
| -4% | -$13.3K | ﹤0.01% | 1260 |
|
|
2018
Q2 | $523K | Sell |
20,241
-1,304
| -6% | -$33.7K | ﹤0.01% | 1094 |
|
|
2018
Q1 | $483K | Sell |
21,545
-3,545
| -14% | -$79.5K | ﹤0.01% | 1106 |
|
|
2017
Q4 | $628K | Buy |
25,090
+5,213
| +26% | +$130K | ﹤0.01% | 1024 |
|
|
2017
Q3 | $481K | Buy |
19,877
+1,127
| +6% | +$27.3K | ﹤0.01% | 976 |
|
|
2017
Q2 | $379K | Buy |
18,750
+982
| +6% | +$19.8K | ﹤0.01% | 1056 |
|
|
2017
Q1 | $478K | Sell |
17,768
-4,708
| -21% | -$127K | 0.01% | 1021 |
|
|
2016
Q4 | $427K | Buy |
22,476
+2,826
| +14% | +$53.7K | ﹤0.01% | 1156 |
|
|
2016
Q3 | $384K | Buy |
19,650
+1,330
| +7% | +$26K | 0.01% | 1055 |
|
|
2016
Q2 | $274K | Buy |
18,320
+783
| +4% | +$11.7K | ﹤0.01% | 1248 |
|
|
2016
Q1 | $161K | Sell |
17,537
-1,810
| -9% | -$16.6K | ﹤0.01% | 1457 |
|
|
2015
Q4 | $373K | Buy |
+19,347
| New | +$373K | ﹤0.01% | 1185 |
|